Management provided a 2026 adjusted total revenue target of $230 million to $270 million, including $35 million to $45 million of Nuvaxovid product sales under existing orders, $40 million to $50 ...
RNA rewards companies that can integrate biology, data science, manufacturing, and clinical development into a single ...
NORTHAMPTON, MA / ACCESS Newswire / April 28, 2026 / Direct Relief and The Pfizer Foundation today announced the third cohort of the Innovation Awards in Community Health, supporting infectious ...
Pfizer Inc. (NYSE:PFE) ranks among the top picks for a retirement portfolio. BMO Capital reaffirmed its Outperform rating and $30 price target for Pfizer Inc. (NYSE:PFE) on September 23 in response to ...
The MarketWatch News Department was not involved in the creation of this content. Repertoire and Pioneering Medicines, Flagship's in-house drug development unit, will jointly conduct research ...
AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE) both reported fourth quarter earnings in early February. AbbVie posted record net ...
Pfizer’s dividend yield has surged to 6.3% after a 55% share price drop since 2021, prompting concerns about its sustainability. Management has pledged to maintain the payout, but payout ratios above ...
Repertoire and Pioneering Medicines, Flagship's in-house drug development unit, will jointly conduct research activities leveraging Repertoire's DECODE™ platform CAMBRIDGE, Mass., Dec. 22, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results